NCT06288204Recruiting
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Association of Green Propolis Extract and Royal Jelly to Modulate Inflammation and Oxidative Stress in Hypertensive Patients and/or With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 153 (estimated)
- First submitted
- 23 Feb 2024
- Start date
- Oct 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- Universidade Federal Fluminense
- NCT number
- NCT06288204
What you commit to
- Study type: Interventional
- Planned participants: 153
- From Oct 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients using catabolic drugs or antibiotics;
Other illness
- autoimmune and infectious diseases,
- diabetes
- cancer
- Patients on regular intake of propolis who are allergic to corn starch or report being allergic to bee stings.
- patients with acute myocardial infarction (AMI) and/or cerebrovascular accident (CVA)
Other
- AIDS
- pregnant women
- patients with catheter access to hemodialysis;
- patients using antioxidant vitamin supplements, prebiotics, probiotics, symbiotic,
Who the study is looking for
- patients in stages 3 and 5 of CKD (GFR from 15 to 59 mL/min),
- patients receiving ambulatorial nutrition treatment at least 6 months
- patients on regular Hemodialysis treatment for at least 6 months
- patients using one to three antihypertensive drugs
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.